Share
Market Research Report

COLORECTAL CANCER THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Therapy TypeChemotherapy (Alkylating Agents, Antimetabolites, and Others) · Immunotherapy (Immune Checkpoint Inhibitors, Oncolytic Virus Therapy, and Others) · Targeted Therapy · and Others
  • By Route of AdministrationOral · Intravenous · Intramuscular · Subcutaneous · and Others
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • Published In30 Mar 2026
  • Report CodeCMI7461
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Colorectal Cancer Therapeutics Market, By Therapy Type
      • Colorectal Cancer Therapeutics Market, By Route of Administration
      • Colorectal Cancer Therapeutics Market, By Distribution Channel
      • Colorectal Cancer Therapeutics Market, Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Epidemiology
    • Pipeline Analysis
  4. Colorectal Cancer Therapeutics Market, By Therapy Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Chemotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Alkylating Agents
        • Antimetabolites
        • Others
    • Immunotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Immune Checkpoint Inhibitors
        • Oncolytic Virus Therapy
        • Others
    • Targeted Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Monoclonal antibodies
        • Small molecule inhibitors
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Colorectal Cancer Therapeutics Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Intramuscular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Subcutaneous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Colorectal Cancer Therapeutics Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Colorectal Cancer Therapeutics Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
      • Regional Trends
    • North America

      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe

      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific

      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East

      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa

      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape

    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ono Pharmaceutical Co. Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ALX Oncology Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Daiichi Sankyo Company, Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Exelixis, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • SOTIO Biotech AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AB Science
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • BioNTech SE
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Effector Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Treos Bio Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology

    • References
    • Research Methodology
    • About us